Literature DB >> 18617333

Spinal nerve ligation-induced activation of nuclear factor kappaB is facilitated by prostaglandins in the affected spinal cord and is a critical step in the development of mechanical allodynia.

D D O'Rielly1, C W Loomis.   

Abstract

This study investigated the effect of 5th and 6th lumbar nerve (L5/L6) spinal nerve ligation (SNL) on activated nuclear factor kappaB (NFkBa) in nuclear extracts from the lumbar dorsal horn of the rat, and its relationship to prostaglandin (PG)-dependent spinal hyperexcitability and allodynia 3 days later. Male Sprague-Dawley rats, fitted with intrathecal (i.t.) catheters, underwent SNL- or sham-surgery. Paw withdrawal threshold (PWT), electromyographic analysis of the biceps femoris flexor reflex, and immunoblotting of the spinal cord were used. Both allodynia (PWT <or=4 g) and exaggerated A- and C-fiber-mediated reflex responses (AFRR and CFRR), featuring decreased activation thresholds and evoked hyperexcitability, were evident only in nerve-ligated animals. This was preceded by an increase in NFkBa in the ipsilateral lumbar dorsal horn at 12 h which was still present 3 days after SNL. The amount of NFkBa in the ventral horns was unchanged compared with sham-controls. Blocking the activation of spinal NFkappaB, either directly with ammonium pyrrolidedithiocarbamate (PDTC; 100 microg i.t.) or indirectly with S(+)-ibuprofen (100 microg i.t.) administered immediately after SNL, prevented the SNL-induced expression of spinal cyclooxygenase-2 and the development of spinal hyperexcitability and allodynia 3 days later. R(-)-Ibuprofen and vehicle had no effect. These results demonstrate that NFkappaB is not only activated by SNL, but that spinal PG generated in the affected spinal cord from the onset of nerve injury facilitates this process. NFkappaB is a critical antecedent in the development of spinal PG-dependent hyperexcitability and allodynia in the SNL model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18617333     DOI: 10.1016/j.neuroscience.2008.04.077

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Spatiotemporal pattern of concurrent spinal and supraspinal NF-κB expression after peripheral nerve injury.

Authors:  Chiu-Wen Chou; Gordon T C Wong; Grewo Lim; Shuxing Wang; Michael G Irwin; Jianren Mao
Journal:  J Pain       Date:  2010-05-26       Impact factor: 5.820

Review 2.  A chronic pain: inflammation-dependent chemoreceptor adaptation in rat carotid body.

Authors:  X Liu; L He; B Dinger; C Gonzalez; L Stensaas; S Fidone
Journal:  Respir Physiol Neurobiol       Date:  2011-03-17       Impact factor: 1.931

3.  Activation of spinal NF-КB mediates pain behavior induced by plantar incision.

Authors:  Tao Yang; Pei Yang; Liu-Ming Jiang; Ri-Yong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Oral administration of cytosolic PLA2 inhibitor arachidonyl trifluoromethyl ketone ameliorates cauda equina compression injury in rats.

Authors:  Mushfiquddin Khan; Anandakumar Shunmugavel; Tajinder S Dhammu; Fumiyo Matsuda; Avtar K Singh; Inderjit Singh
Journal:  J Neuroinflammation       Date:  2015-05-15       Impact factor: 8.322

5.  Spinal NF-κB and chemokine ligand 5 expression during spinal glial cell activation in a neuropathic pain model.

Authors:  Qin Yin; Qin Fan; Yu Zhao; Ming-Yue Cheng; He Liu; Jing Li; Fei-Fei Lu; Jin-Tai Jia; Wei Cheng; Chang-Dong Yan
Journal:  PLoS One       Date:  2015-01-30       Impact factor: 3.240

6.  Upregulation of cystathionine beta-synthetase expression by nuclear factor-kappa B activation contributes to visceral hypersensitivity in adult rats with neonatal maternal deprivation.

Authors:  Lin Li; Ruihua Xie; Shufen Hu; Yongmeng Wang; Tianzhu Yu; Ying Xiao; Xinghong Jiang; Jianguo Gu; Chuang-Ying Hu; Guang-Yin Xu
Journal:  Mol Pain       Date:  2012-12-18       Impact factor: 3.395

7.  NFκB-mediated CXCL1 production in spinal cord astrocytes contributes to the maintenance of bone cancer pain in mice.

Authors:  Jie Xu; Ming-Di Zhu; Xin Zhang; Hao Tian; Jin-Hua Zhang; Xiao-Bo Wu; Yong-Jing Gao
Journal:  J Neuroinflammation       Date:  2014-03-01       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.